Have you ever paused mid-bite into a plate of chicken or paneer tikka and wondered exactly how healthy it really is? Avnish Chhabria did — and that small, nagging curiosity eventually grew into Wellbeing Nutrition, a homegrown nutraceutical brand that nutritionists and pharma veterans alike once told him India simply did not need.
Today, that brand crosses INR 140 crore in turnover, ships to the Gulf and beyond, and has become the first Indian nutrition label to sit on the shelves of UK wellness giant Holland & Barrett. The skepticism Avnish faced when he started talking about building a global nutrition brand out of India turned out to be exactly the gap he needed to fill.
The Skeptics He Decided To Ignore
Avnish's pitch in the brand's early days met resistance from almost everyone he spoke to. Nutritionists told him a global nutrition brand out of India wasn't realistic. Large pharmaceutical companies told him the country didn't even need a health and wellness sector of this kind, since most Indians simply visited a doctor for a prescription rather than reaching for a supplement on their own. Avnish disagreed, and bet that the mindset would shift within a decade.
His reference point was the US, where consumers routinely review their own bloodwork and order vitamins directly from an e-commerce platform without ever booking a doctor's appointment. That direct-to-consumer curve, he realised, was almost entirely missing in India. Back in 2016, even the vocabulary of the category — ‘clean label’, ‘plant-based’, ‘organic’ — barely existed in the Indian market. Wellbeing Nutrition formally launched in January 2020, built around the conviction that India was ready for a global-grade nutrition brand of its own.
A Technology-First Bet In A Crowded Category
Wellbeing Nutrition competes in a category that's anything but empty, going up against names like Oziva, Gynoveda, Power Gummies and Fast&Up, alongside global giants like Amway. Avnish's answer to that competition has been to position the company less as a supplements brand and more as a technology-first healthcare company — one that sources raw materials globally and leans heavily on science and clinical study data rather than marketing alone to justify its multivitamins, sleep aids, collagen peptides and protein lines.
That positioning shows up in where the revenue actually comes from. The company's own website drives nearly two-thirds to seventy percent of total sales, with the remainder split across other e-commerce marketplaces. Avnish has framed this website-first approach as a feature rather than a limitation: it lets the brand control the narrative around ingredients, formulation technology and clinical evidence directly with the consumer, rather than ceding that education to a third-party retail listing.




